From: Fabry disease screening in high-risk populations in Japan: a nationwide study
Group | Enrolled | Variant detected | |||||
---|---|---|---|---|---|---|---|
Gender | n | Age (year) | n (%)$ | Age (year) | |||
Median | IQR | Median | IQR | ||||
a | M | 5505 | 64 | 55–73 | 19 (0.45) | 49 | 40–55 |
F | 3090 | 66 | 56–74 | 9 (0.38) | 58 | NC | |
M or F | 228 | ||||||
b | M | 2853 | 61 | 48–71 | 17 (0.77) | 47 | 37–56 |
F | 1176 | 67 | 54–75 | 12 (1.33) | 47.5 | 33.75–53.75 | |
M or F | 28 | ||||||
c | M | 1926 | 67 | 54–77 | 3 (0.20) | NC | NC |
F | 968 | 72 | 53–82 | 2 (0.27) | NC | NC | |
M or F | 181 | ||||||
d | M | 522 | 13 | 8–31 | 20 (4.98) | 13 | 11–18.5 |
F | 371 | 14 | 9–41 | 10 (3.50) | 13 | 9–25 | |
M or F | 1 | ||||||
e | M | 333 | 28 | 11–45 | 32 (12.49) | 20 | 13–39 |
F | 378 | 36 | 21–49 | 96 (33.02) | 38 | 18.75–49.75 | |
M or F | 4 | ||||||
f | M | 350 | 46 | 16–63 | 3 (1.11) | NC | NC |
F | 206 | 43 | 14–64 | 1 (0.63) | NC | NC | |
M or F | 15 | ||||||
Total | 18,135 | 224 |